Soft tissue sarcoma in the leg
Pro Research Analysisby 
Searched over 200M research papers
Epidemiology and Common Sites of Soft Tissue Sarcoma in the Leg
Soft tissue sarcomas (STS) are rare cancers, making up about 1% of adult malignancies, but they are more common in the extremities, especially the legs, than in other body regions Ebrahimpour2021Eastley2016Gilbert2009+3 MORE. The incidence of STS increases with age, peaking in people over 65 years old, and is more common in males . In the lower leg, foot, and ankle, less than 5% of all soft tissue sarcomas arise, but when they do, they are often challenging to diagnose .
Presentation and Diagnosis of Leg Soft Tissue Sarcoma
Patients with soft tissue sarcoma in the leg typically present with a painless, enlarging mass, though some may experience pain or swelling Jenkins2024Ebrahimpour2021Eastley2016+1 MORE. Symptoms are often present for several months before diagnosis, with an average delay of about 7 months in some cases . Distinguishing between benign and malignant lesions can be difficult, leading to delays and sometimes inappropriate initial procedures Jenkins2024Madireddy2024. Imaging, especially MRI, and biopsy are essential for diagnosis, and these should be performed at specialized centers to avoid errors that could limit treatment options Renn2021Gilbert2009Gamboa2020.
Histological Subtypes and Risk Factors
There are over 50 subtypes of soft tissue sarcoma, with the most common in the leg being undifferentiated sarcoma, mesenchymal tumor, spindle cell sarcoma, and malignant fibrous histiocytoma Jenkins2024Ebrahimpour2021Huñis2022+1 MORE. Some cases have been reported following traumatic injury, but the link between trauma and sarcoma development remains controversial . Other risk factors may include prior radiation exposure and chronic tissue inflammation .
Management and Treatment Approaches
The mainstay of treatment for soft tissue sarcoma in the leg is limb-sparing surgical resection, aiming for wide margins (R0 resection) Gilbert2009Mallick2019Gamboa2020. Radiation therapy is often used for tumors that are not easily resectable or as an adjunct to surgery, while chemotherapy may be considered for high-grade or metastatic disease, though its benefit is still debated Gilbert2009Mallick2019Gamboa2020. Multidisciplinary management, including discussion in a sarcoma board, is recommended to optimize outcomes Jenkins2024Gamboa2020.
Prognosis and Outcomes
Soft tissue sarcomas in the leg, especially in the foot and ankle, have a higher rate of local recurrence and disease-related death compared to other body sites, with a 10-year disease-specific mortality of about 41.7% in some series . The overall five-year survival rate for soft tissue sarcoma is around 50% . Regular follow-up with clinical and radiological exams every 3-6 months is important, especially for high-grade tumors .
Conclusion
Soft tissue sarcoma in the leg is a rare but serious condition that often presents as a painless, enlarging mass. Early recognition, accurate diagnosis at specialized centers, and multidisciplinary management are crucial for improving outcomes. Surgical resection remains the cornerstone of treatment, with radiation and chemotherapy used in selected cases. Delays in diagnosis and inappropriate initial procedures can worsen prognosis, highlighting the need for increased awareness and adherence to established management protocols Jenkins2024Renn2021Ebrahimpour2021+5 MORE.
Sources and full results
Most relevant research papers on this topic
SOFT TISSUE TUMORS OF THE LOWER LEG, FOOT AND ANKLE: A CROSS-SECTIONAL OBSERVATIONAL STUDY ANALYSING 376 CASES.
Soft tissue sarcomas in the foot and ankle are difficult to diagnose, and a management protocol can help reduce inappropriate procedures and improve clinical outcomes.
DOI